Repro Med Shares Owned By Institutions vs. Shares Owned By Insiders

KRMD Stock  USD 4.04  0.11  2.80%   
Based on the measurements of profitability obtained from Repro Med's financial statements, Repro Med Systems may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Repro Med's ability to earn profits and add value for shareholders. As of December 11, 2024, Price To Sales Ratio is expected to decline to 2.26. In addition to that, Days Sales Outstanding is expected to decline to 37.34. At present, Repro Med's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 589.4 K, whereas Income Before Tax is projected to grow to (9.3 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.460.5859
Significantly Down
Pretty Stable
For Repro Med profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Repro Med to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Repro Med Systems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Repro Med's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Repro Med Systems over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(0.26)
Revenue Per Share
0.674
Quarterly Revenue Growth
0.215
Return On Assets
(0.14)
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Repro Med Systems Shares Owned By Insiders vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Repro Med's current stock value. Our valuation model uses many indicators to compare Repro Med value to that of its competitors to determine the firm's financial worth.
Repro Med Systems is rated below average in shares owned by institutions category among its peers. It also is rated below average in shares owned by insiders category among its peers making about  0.12  of Shares Owned By Insiders per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Shares Owned By Insiders for Repro Med Systems is roughly  8.65 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Repro Med by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Repro Shares Owned By Insiders vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Repro Med

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
54.38 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Repro Med

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
6.29 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Repro Shares Owned By Insiders Comparison

Repro Med is currently under evaluation in shares owned by insiders category among its peers.

Repro Med Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Repro Med, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Repro Med will eventually generate negative long term returns. The profitability progress is the general direction of Repro Med's change in net profit over the period of time. It can combine multiple indicators of Repro Med, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-10.3 M-9.8 M
Income Before Tax-9.8 M-9.3 M
Total Other Income Expense Net496.4 K521.2 K
Net Loss-13.7 M-13.1 M
Income Tax ExpenseM4.2 M
Interest Income561.3 K589.4 K
Net Loss-13.7 M-13.1 M
Net Loss-7.8 M-7.4 M
Net Interest Income561.3 K589.4 K
Non Operating Income Net Other121.6 K115.5 K
Change To Netincome1.2 M882.4 K
Net Loss(0.30)(0.29)
Income Quality 0.36  0.37 
Net Income Per E B T 1.41  1.01 

Repro Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Repro Med. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Repro Med position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Repro Med's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Repro Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Use Investing Themes to Complement your Repro Med position

In addition to having Repro Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Materials ETFs Thematic Idea Now

Materials ETFs
Materials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:
Check out Correlation Analysis.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
To fully project Repro Med's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Repro Med Systems at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Repro Med's income statement, its balance sheet, and the statement of cash flows.
Potential Repro Med investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Repro Med investors may work on each financial statement separately, they are all related. The changes in Repro Med's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Repro Med's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.